CClinicalTrials.gg
Status unknownNCT05643352Updated Dec 8, 2022

Barbed Reposition Pharyngoplasty in Patients Complaining of Unilevel Palatal Snoring

An interventional study of Barbed reposition pharyngoplasty in Snoring and Sleep-Disordered Breathing, sponsored by AZ Delta. Status unknown at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-12-08.

Sponsored by AZ Delta · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2022), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the study is to determine whether there is a statistically significant difference in snoring intensity before and after performing a Barbed Reposition Pharyngoplasty as a single-level snoring procedure. The investigators aim to determine whether this is a valid alternative to the more classical techniques of pharyngoplasty. Furthermore, the investigators also wish to map the various postoperative complications and compare them with those of the more conventional techniques. The investigators compare the snoring intensity before surgery with the snoring intensity at 2 weeks (first postoperative control), at 6 weeks (second postoperative control) and at 6 months (Third postoperative control).

For the evaluation of snoring, the investigators use 4 scales/questionnaires. These questionnaires are currently also used as standard at the outpatient clinic for snoring problems. These 4 scales/questionnaires are completed at every check-up.

During the first postoperative check-up, the postoperative side effects are checked (bleeding, infection, readmission, needed consultation with another doctor, date of resumption of work). The investigators also map the pain with a visual analog scale and measure this the day after the operation and let the patient fill it in 3 days, 1 week and 2 weeks after the operation.

02

Conditions studied

  • Snoring
  • Sleep-Disordered Breathing

Keywords

  • Pharyngoplasty
  • Barbed reposition pharyngoplasty
  • Snoring
  • Surgery
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • single-level retro-palatal collapse observed during drug-induced sleep endoscopy (DISE)

Exclusion criteria

Exclusion Criteria:

  • OSAS defined as having an obstructive AHI (OAHI) ≥ 30
  • Obese patients with a body mass index (BMI) ≥ 30 kg/m².
  • Patients with multilevel airway collapse observed during DISE
  • Patients younger than 18 years old.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
16 participants (actual)

Interventions

  • ProcedureBarbed reposition pharyngoplasty

    Barbed reposition pharyngoplasty was performed in all patients

05

What researchers measure

Primary outcomes

  1. Change in Snoring intensity

    Seld-reported subjective score from 0 to 10 that describes the impact of snoring with 0 meaning no snoring and 10 meaning sleeping separately from partner

    Time frame: At 2 weeks, at 6 weeks and at 6 months

  2. Change in Snoring severity

    Seld-reported subjective score that describes the severity of snoring (frequency, duration,...). Score from 0 to 9 with 0 meaning never snoring and 9 meaning snoring every night during the entire night with sounds audible from another floor

    Time frame: At 2 weeks, at 6 weeks and at 6 months

  3. Change in Snoring score

    Seld-reported subjective score that describes the overall loudness of snoring with score of 0 meaning no snoring and 10 meaning extreme snoring

    Time frame: At 2 weeks, at 6 weeks and at 6 months

Secondary outcomes

  1. Change in Epworth Sleepiness Scale

    Seld-reported subjective score that evaluates the presence of hypersomnolence. Score out of 24 with 0 meaning no hypersomnolence and 24 extreme hypersomnolence

    Time frame: At 2 weeks, at 6 weeks and at 6 months

06

Study locations

1 site
  • Neus-, keel- en oorziekten, gelaats- en halschirurgie AZ Delta
    Roeselare, 8800, Belgium
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT05643352
Lead sponsor
AZ Delta
Responsible party
Sponsor
First posted
Dec 8, 2022
Start date
Oct 1, 2022
Primary completion
Dec 2022 (estimated)
Completion
Feb 2023 (estimated)
Last update
Dec 8, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion